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Recent studies have identified a group of cicatricial 
pemphigoid patients who have IgG anti-basement 
membrane autoantibodies that recognize epiligrin, a 
set of disulfide-linked polypeptides closely related if 
not identical to laminin 5 (formerly called kalinin, 
1 nicein, or BM600). To further understand the patho-
physiology of blister formation in these patients, we 
have sought to identify the specific polypeptide(s) 
targeted by their autoantibodies. Comparative stud-
ies show that sera from these patients (nine of nine), 
P1E1 monoclonal anti-epiligrin antibody, and poly-
"' clonal as well as monoclonal anti-laminin 5 antibod-
' ies immunoprecipitate the satne set of disulfide-
linked polypeptides from media of biosynthetically 
radiolabeled human keratinocytes. Moreover, sera 
from eight of nine patients with anti-epiligrin cica-
tricial pemphigoid immunoblot the a subunit of 
laminin 5 but show no reactivity to its f3 or 'Y subunits. 
In addition, circulating IgG front a representative 
, patient was affinity-purified against the a subunit of 
E piligrin is a set of disulfide-linked polypeptides in the extracellular matrix (ECM) of cultured human kerati-nocytes (HKs) that was initially recognized for its ro le in promoting cell adhesion [1 ,2 ]. [, 11ilro, epiligrin binds integrin o:3 {3 1 .in plasma membranes and foca l adhesions 
and co-localizes with integrin o:6{34 in hemidesmosome-Like stable 
anchoring contacts. [, 11i11o, epilig rin is found in the lamina Iucida of 
human epidermal basement membrane (BM) . Recent studies have 
shown that this integrin ligand is a laminin isoform that is closely 
related (if not identical) to lamirtin 5 [3]. Lam in in 5 (formerly called 
; kalinin, nicein, or BM600) is a laminin isoform that has been 
localized to anchoring filaments in human epidermal BM [4-6]. 
Like "classica l" laminin 1, laminin 5 consists of disulfide-linked a, 
{3 , a nd y subunits (specifically, o:3 {33 y 2 ) [7]. The a andy subunits 
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laminin 5 and shown to bind the dermal side of 1 M 
NaCl split skin in the same manner as autoantibodies 
from all patients with anti-epiligrin cicatricial pem-
phigoid. Sera from patients with bullous pemphigoid 
(n = 5), other forms of cicatricial pemphigoid (n = 5), 
epidermolysis bullosa acquisita (n = 4), or bullous 
systentic lupus erythematosus (n = 1) show no reac-
tivity against any subunit of this laminin isoform in 
imtnunoprecipitation or immunoblot experiments. 
These findings correlate with prior reports showing 
that a monoclonal antibody directed against the a 
subunit oflaminin 5 (i.e., laminin subunit a3) induces 
detachment ofhuntan keratinocytes from extracellu-
lar matrix i11 11itvo as well as epidermis from human 
skin i11 situ. Together, these studies suggest that 
lantinin subunit a3 mediates attachment of basal 
keratinocytes to epidermal basement membrane and 
that autoantibodies directed against it may be 
pathogenic. J Invest Demwtol 105:543-548, 1995 
exist as cell-associated precursors of 200 and 155 kD, respective ly; 
these precursors are rapidly processed following secretion to 165 
and 105 kD, respectively [8] . The {3 subunit exis ts as a 140-k:D 
polypeptide that does not undergo processing [8]. In human skin, 
laminin 5 is thought to most closely resemble the fully processed 
form of this heterotrimer. Although the subunits oflaminin 5 show 
substantial deduced amino acid sequence homology to the cotTe-
sponding polypeptides in laminin 1, the a:, {3, and y subunits of 
laminin 5 have significant truncations that are thought to determine 
how this molecule wuquely binds HKs to epidermal BM [9]. The 
recent identification of mutations in gen es encoding laminin 5 
subunits in patients with the potentially lethal , Herlitz's junctional 
epidermolysis bullosa attests to the importance of this complex in 
maintaining adhesion of human epidermis to epidermal BM [10-
12]. 
Recent studies have identified a group of patients with a form of 
cicatricial pemphigoid (CP) who have IgG autoantibodies that bind 
the lower lamina Iucida of epidermal BM and immunoprecipitate a 
distinct set of disulfide-linked polypeptides fi·om HK extracts and 
culture m edium [13-15]. T lus set of polypeptides co-migrates in 
sodi um dodecylsul£1te-polyacrylamide gel electrophoresis (SDS-
PAGE) with the same complex immunoprecipitated by monoclonal 
antibodies directed against epiligt·in or laminin 5. To further 
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unde rstand the pathophysio logy of blister formation in these p a-
tients, we have soug h t to d e termine the precise iden ti ty of the 
polype ptide(s) ta rgeted by their autoantibodies. T h ese studies show 
that autoantibodies from eight of nin e patients w ith anti-epi ligrin 
CP sp ecifica lly target the ex subuni t of laminin 5 (i .e . , laminin 
subuni t ex3). Moreover, circ ul ating IgG fi·om a representative 
patient was affini ty-pudfie d against laminin subuni t ex3 (but not 
con tro l po lypeptides) and shown to bind the derma l side of 1 M 
NaCI separated human skin in the same manne r as autoan tibo di es 
fi·om a ll patients w ith anti-epiligrin CP. T h ese findings suggest that 
laminin subunit a3 p lays a key role in HK ad h esion to epide rm a l 
BM and that autoantibodies directed aga inst it are in volved in the 
p athogenesis of subepith e li al blister formation in patients with this 
fo rm ofCP. 
MATERJALS AND METHODS 
Patients Serum samples were obta ined from nine patients with anti-
epiligrin CP. T he clinica l, histologic, and immunopathologic features of five 
of these patients have been described in deta il elsewhere [14]; the sa li ent 
features of the other four patients arc the same. In brief. all of these patients 
have a mucosa l-p redom inan t subepithe lial b ullous disease and lgG anti-
basement membrane autoa ntibodies that bind the dermal side of 'l M NaC I 
split skin and immunoprccipitate a distinct set o f disul fide -linked polypep-
tides fro m the extracts or media of biosynthctica lly mdiolabeled human 
keratinocytes. Control serum samples we re obta ined from well-character-
ized patients with b ul.lous pemphigoid (BP, n = 5), epidermolysis bu llosa 
acquisita (EBA, n = 4), bullous systemic lupus erythematosus (n = 1 ), other 
forms of CP (n = 5), and normal volunteers (n = 12). Criteria used to 
classify bullous disease control subjects were as fo llows: serum samples from 
patients with BP immunoprecip itated BPAG1 (n = 5) and BPAG2 (n = 3) 
from radiolabcled HK extracts; serum samples from all patients with EBA 
immunoblotted rype VII co ll agen in extracts of lamina densa / dermis; the 
patient with bullous systemic lupus erythematosus sa tisf1cd clinical, Justo-
logie, and immunopathologic criteria fo r this d iagnos is and had circulating 
lgG autoantibodies against rype VII co ll agen ; all patients with o ther forms 
of C P demonstra ted subepithelial blisters of their oral, nasa l, laryngeal, 
conjunctival, and/or esophagea l mucosa, i11 sit11 deposits of immunoreac-
tants in ep ithelial BMs, and circulating lgG anti-13 M autoantibodies directed 
aga inst the epidermal side of 1 M NaCI spli t skin that did not immunopre-
cipi tate 13PAG1 or BPAG2; clinicall )•. the latter patients arc indistinguish-
ab le from those w ith anti-ep iligrin CP. 
Reagents Fluo rescein isothiocyanatc- conjugatcd goat anti-human IgG 
(Tago, Inc., Burlingame, CA), alkali ne phosphatase (AP)-conjugatcd goat 
anti-human IgG (Tago, Inc.), A P-conjugatcd goat anti-rabbit lgG (Tago, 
Inc. ), rabbit anti-lominin 5 antiserum 18 ], normal rabbit serum (GibcoBIU, 
Grand Isle, NY) , and murine monoclona l antibodies directed against 
epi ligrin (P1E1 [1]). laminin 5 (13M 165 [4]), and human lgG 1 (Southern 
Biotechnology Associates , Birmingham, AL) were used as described below. 
Protein A- bearing formalin-fLxed staphylococci (Panso rbin) were obta ined 
from Calbiochem lleh6ng (San Diego, CA) . 
Cell Cultures HK were derived from newborn huma n foreskins and 
cultured in keratinocyte se rum-lice medium (Gibco B'IU) as described 
previously [1 6'1. SCC-25 ce lls (American Type C ulture Collection, Rock-
vill e, MD, C IU 1628) were cu ltured in SO'Yo Ham 's F-12 medium , 50% 
Dulbccco's minimal essential medium, hydrocortiso ne 0.5 mg/ ml, 10% 
heat-inactivated feta l bovine serum, and antibiotics (a ll fro m GibcoBIU). 
Biosynthctic Radiolabcling of HK Culture Medium Subconfluent 
monolaycrs of HK< were metabolicall y rad iolabeled with " S-mcthion ine 
(50 !J.Ci/ml; specifi c activity - 11 00 C i/ mmo l, New Engl;md Nuclear, 
Boston, MA) in methionine-free medi um as described previously (1 7]. 
Rad iolabcl.cd HK cul ture medium was made 1 mM in ethylene diaminetet-
raacetic ac.id and phenylmethylsul fo nyl flu oride, centrifuged at 750 X S for 
1.0 min , recovered, dialyzed against l 0 mM Tris-1-lC I, 150 mM NaCI, pt-1 
7.4 (Tris-buffcred saline [TBS]) at 4°C, and then sto red at - 70°C . 
lmmunoprecipitation lmmunoprecipitation studies of radiolabcled HK 
cul tu re medium were performed as described previously [17,18]. Preclear-
ance stud ies were performed by prcabsorption o f radiolabeled cul ture 
medium with either 50 !J.l of rabbit anti-laminin 5 antise rum o r normal 
rabbit serum (control). lmmunoprec ipitation samples were studied by 
gradient SDS-PAGE and fluorography as described previously [1 7]. 
Laminin 5 Laminin 5 was iso lated fro m the ECM of cultured HK as we ll 
as the cultu re media of SCC-25 cells and used in immunoblot >eudies as 
described below. In brief, confluent cultures of J-IK were sequentiall y 
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extracted with 1 •:;,, Triton X- 1 00 in phosphate-bufFered saline, 2 M urea in 
1 M NaC I, and 8 M urea to yield culture dishes coated w ith ECM rich in 
laminin 5. U rea-insoluble proteins were detached from the surface of 
cul ture dishes with a disposable cell scrapper (Costar Corporation, Cam-
bridge. MA) and suspended in 0.5% w/v SDS as desc ri bed previously [1]. 
Al l extraction bufFers contained 1 mM phenylmethylsul fonyl fluoride and 2 
mM N-ethylmaleimidc. The J-11{ ECM extract was dia lyzed against 0.1 % 
SDS in TBS at 4°C, concentrated by exposure of dialysis units to Sephadex 
G-75 (Pha rmacia, Uppsala, Sweden) , and stored at - 70°C. T he conditioned 
medi um of SCC-25 cel ls was used as another source of laminin 5. In brief, 
over a period of 2 to 3 d, SCC- 25 cell s (80'1., density) were adapted to their 
basa l medium fi·ce of fetal bovine serum. Following 24 to 48 h of additional 
cul ture, the conditioned medium of these cells was recovered, centrifuged 
at low speed to remove cell debri s, and then incubated with ammonium 
sul f.1te (300 mg/ml) overn ight on icc . After centrifugation (- 1 0,000 X g for 
60 min), the pellet was resuspended in 65 mM NaCI, 1 mM eth ylenedia-
minetetraacctic acid , 25 mM Tris , pH 7 .5, made 4 !J.g/ ml with diisopropyl 
fluorophosphate, dia lyzed against the same Tris buffer, microfuged at 
14,000 rpm for 30 min at 4°C. and stored at - 70°C. 
ImnHmoblotting Prote in electrophores is was performed according to 
the method established by Laemmli using 6% SDS- PAGE gels [19]. 
R esolved proteins were transferred to nitrocellu lose paper as described by 
Towbin using the NOVEX system (San Diego, CA) [20]. N itrocellulose 
sheets were blocked overnight at 4°C in TBS conta ining 3% bovine serum 
albumin and then cut into strips. Experimenta l and control sera were diluted 
1:200 in 0.5% Triton X-100 in TBS (WBS) and applied to ni trocellulose 
strips containing laminin 5 fo r 2 h at room temperature . Rabbit anti-laminin 
5 antiseru m and normal rabbit serum (both at 1:1000) were used as positive 
and negative controls, respectively, to specifica ll y identify ail laminin 5 
subuni ts (i. e., processed and unprocessed ex , {3, and y subunits). Following 
their incubation w ith first- step antibodies, ni troce lJulose strips were washed 
five times with an excess volume of WBS (5 min per wash) . Second-s tep 
antibodies (AP-conjugated goat anti-huma n lgG or AP-conjugated goat 
anti-rabbit lgG in the case of contro ls) were diluted 1:1000 in WBS and 
incubated w ith strips for 2 h at room temperatu re and then washed in the 
same manner described above. lmmunoblots were deve loped for 3 min 
(A P-conjugate substrate kit, Bio-Rad Laborato ri es , Hercules, CA) then 
washed extensively with TBS. 
Affinity-Purification Studies To show that anti-laminin 5 antibodies in 
the sera of patients with anti- epiligrin C P arc specifi ca ll y reactive •Nid1 
human epidermal BM, lgG fi·om a representative patient was affi•ury 
puri fied aga inst laminin subunit cx3 (o r contro l polypeptides) immobilized 
on nitrocellulose paper and tested against 1 M NaCI sp lit skin by indirect 
immuno Auorescence microscopy as described previously [21,22]. In brief, 
HK ECM was reso lved by electrophores is and transferred ro nitrocellulose 
paper as described above. Horizontal strips of nitrocellulose paper contain-
ing laminin subunit cx3 (or 140-kD ECM polypeptides, control) were 
incubated with patient serum (1 :5 in TllS) overnight at 4°C and then 
washed extens ive ly with 0.5% polysorbate 20 in TBS . Bound antibody was 
eluted fro m experimental and control ni trocell ulose strips with 50 mM 
glycine in 500 mM NaC I, pH 2.3, neutrali zed immediately wid1 500 mM 
Na 2 HP0 ,1, pH 6.5, dialyzed against TBS for 16 h at 4°C, and concentrated 
by ultrafiltration (Centricon 30, Amicon Corporation , Danvers, MA). 
Afliniry-purified antibodies were tested aga inst 1 M NaCI spli t skin br 
indirect in1111lli10fluorcscence 1nicroscopy usjng fluoresce in isoth.iocyanate-
conjugated goat anti-human lgG as a second-step antibody [22]. 
RESULTS 
Circulating IgG from Patients with Anti-Epiligrin CP Im-
munoprccipitatc Laminin 5 Comparative studies demonstrate 
tha t serum fi·om a rep resentative patient with a n ti-epiligrin CP, 
P1 E 1 m o n oclonal an ti- e p.iligrin antib o d y, and polyclonal as well as 
m o n oclo n a l anti-l aminin 5 an tibod ies all immuno precipitate the 
sam e set of disu lfide- linked polypep t ides fi·om th e media ofbiosyn-
thetica lly radio labe lcd HKs (Figs 1 and 2). The predominant 
polypeptides (and corresponding laminin 5 subuni ts) in this com-
p lex consist of th e fo llowing: a doub le t of - 200 and - 190 kD (the 
unprocessed ex subunit and a similar polypeptide [see b e low], 
respective ly); a doublet of - 1 65 and - 155 kD (the processed a and 
the unprocessed ')'subunits, respectively); a doublet of - 145 and 
- 140 kD (a minor fragment of the ex subunit [va riably present in 
such immunoprecipitation studies [8]] and the f3 subunit, respec-
tively); and a polypeptide of - 105 kD (the processed y subuni t). 
T his complex is n ot recognized by a control monoclonal antibody 
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Figure 1. Circulating IgG from patients with anti-epiligrin CP 
immunoprecipitates laminin 5. Medium from -' 5S-mcthionine biosyn-
.; tberica lly radiolabeled human keratinocytes was prcabsorbcd with normal 
h uman , tnousc, and rabbit serum , tlvicc rnixcd \Vit h aliquots of fi·eshl y 
wash ed Pansorbin , and then studied in immunoprccipitation experiments as 
previous!)• described p 7, 18]. lmmunoprccipi tation samples were applied to 
SDS-polyacrylamide gels and studied by fluorography. T he comparati ve 
immunoprecipitation study shown here utilized the fo llowing: DM1 65 
mon oclonal anti-laminin 5 an tibody (l aue 1); P1 E1 monoclonal an ti-
epiligrin antibody (lau e 2); monoclonal anti-human lgG 1 antibody (negative 
con trol , laue 3); rabbit anti-laminin 5 antiserum (laue 4) ; normal rabbit 
serum (negative contro l. la11e 5); scrun1 fi·on1 a represen tative pat ien t with 
anri- epiligrin C P (la11e 6); and normal human serum (negative control, laue 
7). B Ml65 (laue 1), p·r E1 (la11e 2), rabbit an ti-lam in in 5 antiserum (la11e 4), 
and scrurn fro n1 o ur represen tative pa tien t with anti-cpiligrin C P (ln11e 6) all 
irnm unoprccipi tote the same se t of di sulfide-linked polypeptides of 200, 
165 , 155 , 140, and 105 kD. T his complex is not immunoprecipitated by 
monoclonal anti-human lgG 1 antibody. normal rabbit serum , or normal 
human serum (negative controls, ln11es 3, 5, a111l 7, respec ti ve ly). Preclear-
ance of n1cdia wi th rabbit an ti-fi bro nectin an tibo dies removed the in tense 
band of 240 kD seen in all of these immunoprecipi ta tion samples. 
o r sera fro m a no rmal rabbit o r no rmal hum an volunteer. More-
over , preclea rance of radio labe led HK m edia w ith rabbit anti-
larninin 5 antiserum (bu t no t contro l no rm al rabbit serum) re m o ved 
all p olypep tides reactive w ith serum fro m a representative patient 
with anti-epilig rin C P (data not sho wn). Sera fi·om all pati en ts with 
anti- epi.lig rin C P immun oprecipita te this sam e set o f polypeptides. 
In contras t, se rum samples fi·om con tro l patien ts w ith BP (n = 5) , 
CP (n = 5) , EBA (n = 4) , o r bullo us syste mic lu p us e rythe m atosus 
(n = 1) as we ll as no rmal voluntee rs (n = 12) d o no t. 
All comparative immun o precipita t io n studies u t ilized biosyn-
thetica lly radio labe led m edia fi·om subconAuen t m o no layers o fHKs 
to minimize the presence o f other laminin isofo rms (e.g., laminin 6, 
cx3 {3 1 y 1) that tend to accumu late in pos tconAu en t c ul tures. N o ne-
theless, the - 190-kD po lypeptide immun o precipitated b y all ex-
perim ental (but not control) antibo di es is tho ugh t to represent a 
crossreactive o r co-precipitating laminin subuni t. T he inte nse band 
of - 240 kD seen in all immunoprecipi tation sa mples (Fig 1) was 
confirm ed in preclearance studies to be fibro nectin. 
Circulating IgG from Patients with Anti-Epiligrin CP Im-
m u.noblot the a Subunit ofLan~inin 5 In immuno blot studies 
of HK ECM , rabbi t an ti-laminin 5 antiserum identifi es fi ve 
polypeptides con·espo nding to th e unprocessed and processed a 
Sl.lbunits (- 200 and 165 kD, respec tively) , the f3 subunit (- 140 
AUTOANT1130DIES AGA INST LAMIN IN a 3 545 
2QQ-..165k0 
a3 
y2 
140kD 
Figure 2. Laminin 5 is a hcterotritnedc protein composed of 
disulfide-linked a, {3, and ')'subunits. T he a subuni t exists as unproc-
essed and processed polypeptides of 200 and 165 kD. respecti ve ly. The {3 
subunit is a 140-kD polypeptide that docs not undergo processing fo llowing 
syn thesis o r secre tio n . T he ')'s ubuni t of latnin.in 5 exists as unprocessed and 
processed polypeptides of 155 and 1 OS kDs, res pectively. Serum-free 
conditioned media ofS CC-25 ce ll s was treated wi th ammonium sul f.1te (300 
mg/ ml) to yield a precipitate that was res uspended in T ris bu fFer. reduced, 
applied to SDS-pol)•act) •lamide gels, transferred to ni trocellulose paper, and 
then immunoblotted wi th rabbit anti-laminin 5 antiserum (lcji). Similarly. 
conAu cnt cul tures of hun tan ke ra tinocytcs w ere sequen tially cxtrncted with 
1 •:;., T riton X-1 00 in phosphate-bufFered s:J l.ine, 2 M urea in 1 M NaC I. and 
8 M urea to yield ECM proteins tha t were scrapped from the surface of 
cul ture dishes, concentrated, reduced, applied to S.DS-polyacrylamide gels, 
and then studied by immunoblot wi th rabbit anti-laminin 5 anti serum 
(right) . T he insets sho \v the va rious latniniu 5 subuni ts in th e rncdia of 
SCC-25 cells (lcji) and the ECM of human kcratinocytcs (right) . T he sam e 
rabbi t an ti-laminin 5 antise rum was nsed as a positive control in the 
experiments shown in Figs 3 and 4. 
k.D), and the unprocessed and processed y subunits (- 155 and 105 
k D , respecti ve ly) of this laminin isofonn (Fig 2). N on e of these 
polypep tides are bo und by norm al rabbit serum (negative contro l, 
data not sh o wn) . C irculating lgG from e ig ht o f nine patien ts· w ith 
anti-e pilig rin C P bind polypeptides of 200 and 165 kD th at 
comig rate in SDS-PAGE with unpro cessed and processed a sub-
tmits of la m in in 5, respectively (Fig 3) . N o ne of these sera bOtmd 
polypeptides corresp o nding to the f3 o r y subunits; circulating lgG 
autoantibo dies ti·o m the patien t that did not immuno blo t any 
laminin 5 subunit d o immuno precip itate this protein , presumably 
via recognitio n of a con fonn ational determinan t . Serum samples 
fro m pati e n ts w ith o ther fo rms of CP (n = 5), BP (n = 5), EBA 
(n = 4) , o r bullo us sys te mic lupus eryth em atosus (n = 1) as w e ll as 
12 no rma l volunteers show no reactiv ity to po lypeptides corre-
spo nding to any laminin 5 subunit in these immuno blo t studies. 
Because the conditio ned m edium of SCC-25 cells represen ts a 
w e ll-characterized source of laminin 5, addi tional immuno blot 
studies were conducted on this m ate rial. In these experiments, 
rabbit an ti-laminin 5 antiserum ide ntifies fo ur po lype ptides of 
- 165, 15 5, 140, and 1. 05 kD that correspo nd to the laminin 5 
subunits d escl'ibed above (Fig 2) . C irculati ng IgG fro m fi ve of five 
patie n ts w ith anti-epiligrin C P bind a sing le 165-kD polypeptide in 
SCC-25 m edium that corresponds to the processed a subuni t of 
laminin 5 (Fig 4) ; sera fro m the fo ur ocher patients w ith an ti-
e piligrin C P were no t tested against thi ~ antigen source. Serum 
samples fro m patients w ith o ther sube pide rmal bullo us d iseases 
(n = 1 5) o r 11 no nnal volunteers do not bind any subtmit o f 
laminin 5 in these immuno blo t studies . Inte re stingly, circ u.l a ting 
IgG from o ne no m1 al volunteer bi11ds a po lype ptide in the m e dia of 
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Figure 3. Circulating IgG from patients with anti-epiligrin CP 
identifies the a subunit of laminin 5 isolated from the ECM of 
human keratinocytes on immunoblots. The ECM of human keratino-
cytes was iso lated, reduced, applied to 50S-polyacrylamide gels, and 
studied by immunoblot as described in the legend of Fig 2. Sera from 
representative patients with anti-epiligrin CP (ln11es 1 a111/ 2) specifically 
immunoblot the 200-kD unprocessed and 165-kD processed a subunits of 
laminin 5 in 1-IK ECM. Sera from patients with BP (/n11 es 3 allfl 4), other 
forms ofCP (lmiCS 5 allfl 6) , EBA (ln11es 7 allf/ 8), or a normal volunteer (l a11e 
9) do not bind any laminin 5 subunits. 
SCC-25 cell s that appears to co-migrate in SDS-PAGE with the 
processed a3 chain of laminin 5. However, when this serum sample 
was tested by indirect immunoflu o rescence microscopy using 1 M 
NaCJ separated human skin , no !gG anti-BM autoantibodies were 
LamS NHS BP CP EBA 
165 kD 
Figure 4. Circulating lgG from patients with anti-epiligriu CP iden-
tifies the a subunit oflaminin 5 isolated from the conditioned media 
of SCC-25 cells on inmtunoblots. The serum-free conditioned media of 
SCC-25 cells was isolated, reduced, applied to 50S-polyacrylamide gels, and 
sn1died by immunoblot as described in the legend of Fig 2. Sera from 
representative patients with anti-epiligrin CP (ln11 es 1, 2, a111l J) bind the 165-kD 
processed a subtmit of laminin 5. Sera from nonnal volunteers (ln11es 4, 5, a11d 
6) as well as patients with BP (la11es 7 a11d 8) , other fonns ofCP (la11es 9 a11d 10). 
and EBA (/n11es 11 a11d 12) do not immunoblot any laminin 5 subunits. 
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detected. Moreover, this volunteer's serum did not immunopre-
cipitate any po lypeptides from radiolabcled HK extra cts and media 
or immunoblot laminin 5 in HK ECM (sec above). Solitary 
polypeptides in this antigen source that are bound by circulating 
IgG from certain subjec ts signify patient-specific but not disease-
specific reactivity . 
Affinity-Purified Anti-Laminin 5 IgG Autoantibodies (a 
Subunit Specific) Bind the Dermal Side of 1 M NaCI Split 
Skin To determine if circulating anti-lam in in 5 antibodies in our 
patients are reactive with human epidermal BM , lgG fi·om a patient 
with higher titers of these autoantibodies was affinity purified 
against the a subunit of laminin 5 immobilized on nitrocellulose 
paper and tested against 1 M NaCI split skin by indirect immwlo-
flu o rescen ce microscopy. As a control, serum from the same patient 
was afrlnity-purified against 140-kD polypeptides in the same 
antigen source (i.e., HK ECM) . Patient lgG affinity purified against 
the a subunit of laminin 5 (i .e ., laminin a3) specifically bound the 
dermal side of i M NaCI split skin in the sam e ma1mer as 
autoantibodies in the sera of tlus and other patients with anti-
epiligrin CP (Fig SA) . In contrast, eluates fi·om control polypep-
tides showed no staining of 1 M NaCI split skin (Fig SB). 
Moreover, because the molecular w eight of these control polypep-
tides corresponds to the {3 subunit oflaminin 5, nega tive findings in 
these indirect immunofluorescence microscopy experiments con-
fe rs even greater spec ificity about the reactivity of these patients' 
circulating autoantibodi es against the a subunit of this hc terotri-
n1er. 
DISC USSION 
Patients with anti-epiligrin CP have lgG autoantibodies that bind 
the extracellular matrix of cultured HK as well as the lower lamina 
Iucida of human epidermal BM (13-15]. In addition, these patients' 
anti-BM autoantibodies have been shown to immunoprecipitate a 
distinct set of disulfide-li nked polypeptides from extracts and m edia 
ofHK (13 ,14]. Comparative immunoprecipita tion and preclearance 
studies have shown that this complex is the sam e as that identified 
by monoclonal antibodies directed against epiJigrin or laminin 5. 
These autoantibodies have been used as a disease-specific marker 
for patients with this form of C P, because sera fi·om patients wir:h 
other form s ofCP, other subepidermal bullous diseases, and normal 
volunteers do not immunoprecipitate tlus complex [1 3,14]. Immu-
noprecipitation studies such as those described above assess m e 
binding of antibodies to antigens under nonreduced and nondena-
turing conditions (i. e. , conditions in which disu.lfide-bonded 
polypeptides remain associated and retain their tertiary structure). 
In such studies, it is not possible to discem which polypeptide (or 
polypeptides) within a complex are specifically targe ted by a 
patient's autoantibodies (or similarly, if all patients are targeting the 
same polypeptide within a complex). T he objective of this study 
was to de te rmine which polypeptide (s) w ithin this complex is (are) 
bound by autoantibodies from patients with anti-epiligrin CP. The 
rationale is that this information would fi.1rth cr our understanding 
of the pathophysiology of tlus disease and elucidate the function of 
the adhesion molecule targeted by these patients' autoantibodies. 
To address these questions, we performed additional comparative 
immunoprecipitation and preclearance studies to confirm that these 
patients ' autoantibodies and well-characterized polyclonal and 
monoclonal anti-lami1un 5 antibodies identify the same complex of 
disu lfide- linked HK polypeptides. These studies confirm that mul-
tiple antibodies directed aga inst laminin 5 or epiligrin immunopre-
cipitate the same set of polypeptides from biosynthetically radiola-
bcled HK cul ture m edia . We next tested these patients' sera (and 
that of controls) aga inst reduced laminin 5 by immunoblotting- an 
experimental sys tem in which disulfide-bonded polypeptides are 
separated and denatured. These studies were practical because the 
synthesis, processing, and isolation of laminin 5 has been recently 
detailed and because a polyclonal anti-laminin 5 antiserum reactive 
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Figure 5. Affinity-purified anti-laminin 5 IgG autoantibodies (t.r 
subunit specific) bind the dermal side of l M NaCI split skin. 
Monolayers of cultured human keratinocytes were sequentially extracted to 
yi.eld ECM proteins that were solubilized, concentrated, separated on 
SDS-polyacrylamide ge ls, and then transferred to nitrocellulose paper. 
Horizontal strips of nitrocellulose paper containing the a subunit oflan1inin 
5 (or identical amounts of nitrocellulose paper containing 140-kD polypep-
tides, negative control) were incubated w ith scrmn fron1 :1 representative 
patient with anti-epiligrin CP (diluted 1 :5 in Tris-buffercd sa line} overnight 
at 4°C. The strips were washed extensively with 0.5% polysorbate 20 in 
Tris-bulfered saline and the bound antibody was eluted from experimental 
and control nitrocellulose strips with 50 mM glycine in 500 mM NaCI. pH 
2.3. E luates were neutralized immediately with 500 mM Na2 HP0,1, pH 6.5, 
dialyzed against Tris-bulfercd saEne for 16 h at 4 °C, and concentrated by 
ultrafiltration. Affinity-purified autoantibodies were tested against 1 M 
NaCI split skin by indirect immunoAuorescence microscopy using Auores-
cein isothiocyanate-conjugated goat anti-human IgG as a second-step 
antibody. lgG from a representa tive patient with anti-epi ligrin CP affinity 
purified against the a subunit of laminin 5 binds the dermal side of 1 M 
NaCI split skin in the same manner as circulating autoantibodies in the sera 
of this and other patients with this di sorder (A). lgG from the same patient 
that is affinity purified against 140-kD polypeptides in the same antigen 
source does not bind epidermal BM (B). 
with all subunits of tlus laminin isoform was avai lab le for use as a 
positive control [ 4,8). These studies found that autoantibodies from 
eight of tune patients with anti-epiligrin CP bind the a subunit of 
lamin.in 5, and that none of these patients' sera show reactivity to 
the f3 or '}' subunits of laminin 5. The one patient that did not 
, immunoblot any laminin 5 subunit presumably has circulating 
autoantibodies directed against a conformationa.l determinant on 
this protein (i.e., a determinant detectable by immunoprecipitation 
but not by immunoblot). The reactivity of these patients' autoan-
tibodies against the a subunit oflaminin 5 is further specific in that 
no laminin 5 subunits were immunoblotted by autoantibodies from 
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patients with other forms of CP or other subepidermal bullous 
diseases. Moreover, it was possible to affinity purify the circulating 
autoantibodies of a representative patient against the a subunit of 
laminin 5 immobilized on nitrocel.lulose paper and show that this 
specific lgG binds the dermal side of1 M NaCI split skin in the sam e 
manner as autoantibodies in the sera of all patients with anti-
epiligrin CP. These fmdings all indicate that the a subunit of tlus 
laminin isoform (i.e . , laminin a3) is specifically targeted by autoan-
tibodies in patients with this form of CP. On a practica l level, these 
studies also demonstrate that autoantibodies in patients with this 
form of CP can be identified by immunoblotting-a laboratory 
technique that is more widely available than immunoprecipitation 
and that hopefully can be used to identify additional patients with 
tlus disorder. 
Findings in tlus study correlate with several prior observations. 
First, it has been previously shown that the stoichiometric ratio of 
the po lypeptides immunoprecipitated by autoantibodies from pa-
tients with this fonn of CP is always the same [13 ,14). Tlus 
consistem finding has suggested that tl1ese patients' autoantibodies 
are ta rgeting the same polypeptide within this disulfide-linked 
complex, a suggestion confinned by the immunoblot findings 
presented here. Second , our finding that patients with this form of 
CP target the a subunit of laminin 5 correlates with prior srudies 
showing that this particular subunit plays an important ro le in 
promoting HK adhesion to extracellular matrix ;,, 11itro and epider-
mal BM ;, 11i11o. Specifically. Rousse l.l e et nl have shown that a 
monoclonal antibody (i.e ., monoclonal antibody BM165) directed 
against this lantinin submut causes H.Ks to round and detach from 
cu lture dishes ;, 11itro and skin fragments to split within the lamina 
Iucida ill sit11 [ 4]. Findings in our cun-ent study support the 
suggestion that this subunit of lamin.in 5 m ediates attachment of 
HKs to epidem1al BM and further suggest that autoantibodies in 
patients with this form of CP may be pathogenic. Third, prior 
studies have identified mut;ltions in lamin in 5 subunits in patients 
with H erlitz's junctional epidermolysis bullosa (1 0-12), an inher-
ited and potentially lethal subepidermal buJious disease. In terest-
ingly, patients with anti- epiligrin CP share some clinical features 
seen in patients with tlus form of junctional epidermolysis bullosa. 
For example, both groups of patients have noninflammatory, 
subepithelia.l bullous lesions that fi·equently affect tl1e mouth, 
nasopharynx, larynx, a.nd esophagus. In contrast, patients with 
anti-epiligrin CP have lacked extensive cutaneous involvement or 
abnormalities in their nails and tee tl1 that are characteris tically seen 
in patients with H erlitz 's disease. These unexplained phenotypic 
differences may relate to tissue-specific or developmental variances 
in the relative amounts or biologic activities of laminin 5 in mucosal 
ve rsus cutaneous or neonatal versus adu lt .BMs. In any event, 
acquired or inherited abnormalities in this anchoring filament 
associated prote in result in separation of human epidermis from 
epidermal BM. 
Gudu/a Ki11schig was suppmred by a graut •?I the Delllsche Forsclumgsgc~~t ciuschafi, 
a111l R11bc11 E. B111geso11 by USPHS grau1 AR 35689. 
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ANNOUNCEMENT 
The Dystrophic Epidermolysis Bullosa R esearch Association of America (D .E.B .R.A.) 1995 
R esearch Grant was awarded by the D ermatology Foundation to J effe rson Medical Coll ege in 
Philadelphia in support of a research proj ec t "Development of a PCR-Bascd Mutation 
D e tection Kit for the Type VII Collagen Gene: Applica tion to Prenata l Diagnosis of the 
Dystrophic Forms of Epide rmolysis Bullosa" (Principal Investigator: Dr. Angela M . C hri s-
tiano) . 
With the support of this grant, a testing kit, including appropriate oEgomer primers , PCR 
ampEfication conditions, and other technjca l in formation, is now available. T he Department of 
Dermatology at J efferson will provide, free of charge, eight of these kits to investigators for the 
diagnostic purpose, a!Jowing a universally accessible strategy for accurate diagnosis and 
first-trimester DNA-based prenatal diagnosis to fa milies at risk for recurrence of the dystrophic 
forms ofEB. 
lnvestigators in terested in this offer should contact J efferson Dermato logy at the address 
below, with information indica ting the potentia l usefu lness of this kit for their resea rch and/ or 
clinical service . 
Jouni Uitto, M .D ., Ph.D. 
Department of D ermatology 
J efferson Medica l Co!J ege 
Philadelphia, PA 191 07-5541, USA 
Tel. : (215) 955- 5785 
FAX: (215) 955-5788 
E-mail: juitto@lac.jci. tju .edu 
